Leadership

Experienced executive team: Auna's leadership team brings significant healthcare and regional operating experience, with the CEO and key executives having held senior roles in Latin American healthcare and finance sectors, supporting credibility and sector expertise.

Clear strategic vision: Management has articulated a focused strategy to expand integrated healthcare services in core Latin American markets, emphasizing operational scale and patient outcomes.

Credibility with stakeholders: Auna's leadership has established relationships with regional regulators and investors, demonstrated by successful capital raises and regulatory approvals for recent expansions.

Auna's executive team demonstrates strong sector expertise and a clear vision for regional healthcare leadership. Their track record in stakeholder engagement and operational execution supports above-average leadership quality.

Strategy Execution

Consistent revenue growth: Auna has delivered multi-year revenue growth above regional healthcare averages, driven by organic expansion and selective acquisitions.

Operational integration: Management has effectively integrated acquired clinics and hospitals, maintaining service quality and cost controls, which is reflected in stable margins despite expansion.

Return on equity: Auna's return on equity of 11.9% TTM is competitive for the sector, indicating disciplined execution and capital efficiency.

Auna's management has a strong record of delivering growth and integrating new assets, with financial metrics supporting effective execution. However, continued leverage and expansion risks warrant monitoring.

Capital Allocation

Aggressive leverage profile: Auna's debt-to-equity ratio of 2.2x and net debt/EBITDA of 4.3x are elevated versus peers, reflecting a willingness to use debt to fund growth.

Reinvestment focus: Management has prioritized reinvestment in clinical infrastructure and network expansion over dividends or buybacks, aligning with growth strategy.

Selective M&A discipline: Recent acquisitions have been targeted and accretive, but the pace and scale of deals increase financial risk given current leverage.

Auna's capital allocation is growth-oriented, with a bias toward reinvestment and M&A. While this supports expansion, the high leverage profile introduces balance sheet risk and limits flexibility.

Governance

Board composition: Auna's board includes a mix of independent and affiliated directors, but independent representation is below global best practices.

Transparency and reporting: The company provides regular financial disclosures and has improved reporting standards post-IPO, but some governance structures remain less mature than global peers.

Shareholder alignment: Management and board members hold meaningful equity stakes, aligning interests with shareholders, though related-party transactions require ongoing scrutiny.

Auna's governance framework is improving, with progress in transparency and alignment. However, board independence and governance maturity lag global standards, representing a moderate risk.

Succession Planning

Key person risk: Auna's leadership is concentrated among a few founders and senior executives, increasing exposure to key person risk.

Bench depth: There is limited public disclosure on succession planning or the depth of the executive bench, which is common for regional healthcare operators.

Recent management stability: The executive team has remained stable through recent growth phases, but formal succession processes are not well documented.

Auna's succession planning is underdeveloped, with key person risk and limited transparency on leadership continuity. This is a common challenge among regional growth companies but remains a moderate concern.

Overall Score

Auna's management demonstrates strong leadership and execution capabilities, but higher leverage than previously reflected weighs more heavily on the overall profile. Governance and succession remain moderate concerns, and the company is well positioned for continued expansion, though balance sheet risk requires closer monitoring.